Search research articles
Contact Us
Filters
Showing results (361-370 of 362) with videos related to
Page
of 37
Sort By:
You have reached the last page of results.
This site can display upto 362 results.
The Lancet. Infectious Diseases
|
August 6, 2023
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial
Betty Mwesigwa, Katherine V Houser, Amelia R Hofstetter, et al.
Lancet (London, England)
|
January 28, 2023
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial
Melinda J Hamer, Katherine V Houser, Amelia R Hofstetter, et al.
Page
of 37
Search research articles
Search
Showing results (361-370 of 362) with videos related to
Sort By:
Page
of 37
You have reached the last page of results.
This site can display upto 362 results.
The Lancet. Infectious Diseases
|
August 6, 2023
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial
Betty Mwesigwa, Katherine V Houser, Amelia R Hofstetter, et al.
Lancet (London, England)
|
January 28, 2023
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial
Melinda J Hamer, Katherine V Houser, Amelia R Hofstetter, et al.
Page
of 37